Low adherence to guidelines in non-muscle-invasive disease
Authors:
- 31 August 2016
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 13 (10) , 570-571
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology, 2017
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineJournal of Urology, 2016
- Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of AlbertaCanadian Urological Association Journal, 2016
- Versorgungsstandard bei neu diagnostiziertem BlasenkarzinomDer Urologe, 2013
- Current clinical practice gaps in the treatment of intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer ( NMIBC ) with emphasis on the use of bacillus C almette‐ G uérin ( BCG ): results of an international individual patient data survey ( IPDS )BJU International, 2013
- Challenges in non‐muscle invasive bladder cancer: lessons from a regional reviewAnz Journal of Surgery, 2011
- Compliance with guidelines for patients with bladder cancerCancer, 2011
- Are Referral Centers for Non-Muscle-Invasive Bladder Cancer Compliant to EAU Guidelines? A Report from the Vesical Antiblastic Therapy Italian StudyUrologia Internationalis, 2010
- Treatment of nonmuscle invading bladder cancer: Do physicians in the United States practice evidence based medicine?Cancer, 2009
- Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care ProjectJournal of Urology, 2008